BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities


   

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Apr 6, 2011 Aldagen, Inc. N/A N/A N/A $80.5M N/A N/A

Lead Underwriter

N/A

Description

Aldagen, Inc., a biopharmaceutical company, develops adult stem cell products for tissue repair and regeneration. The company focuses on developing product candidates to address cardiovascular disease.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Nov 11, 2010 Ikaria Inc. N/A N/A N/A $12-13 Per Share N/A N/A

Lead Underwriter

Goldman Sachs, Morgan Stanley, Credit Suisse, and Lazard Capital Markets.

Description

Ikaria is positioned to develop and deliver innovative therapeutics and interventions to meet the needs of critically ill patients.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Feb 4, 2010 Taminco N/A N/A N/A $590.6M N/A N/A

Lead Underwriter

Commerzbank and Rabo Securities

Description

Taminco is the world's largest producer of alkylamines and derivatives.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

April 9, 2009 Alimera Sciences N/A N/A N/A $75M N/A N/A

Lead Underwriter

Credit Suisse and Citi

Description

Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
Sep 9, 2008 INSYS Therapeutics N/A N/A N/A N/A N/A N/A

Lead Underwriter

UBS Securities

Description

INSYS Therapeutics is a biopharmaceutical company focused on discovering, developing and commercializing innovative products to address chemotherapy-induced nausea and vomiting (CINV), pain management and other central nervous system disorders.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Sep 3, 2008 Codexis Pharmaceuticals N/A N/A N/A N/A N/A N/A

Lead Underwriter

Credit Suisse and Goldman Sachs

Description

Codexis is a leading developer of biocatalytic chemical processes that can dramatically reduce manufacturing costs across a broad range of industries.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Aug 5, 2008 Zogenix, Inc. N/A N/A N/A N/A N/A N/A

Lead Underwriter

N/A

Description

Zogenix is a specialty pharmaceutical company whose goal is to uniquely enhance and differentiate medicines by incorporating innovative technologies in an effort to relieve suffering in people with CNS and pain disorders.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Jun 27, 2008 Bayhill Therapeutics, Inc. N/A N/A N/A N/A N/A N/A

Lead Underwriter

N/A

Description

Bayhill Therapeutics is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA™ platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Jun 10, 2008 Peplin Inc. N/A N/A N/A N/A N/A N/A

Lead Underwriter

N/A

Description

Peplin is a development stage specialty pharmaceutical company, founded in 1998, focused on advancing and commercializing innovative medical dermatology products.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

May 12, 2008 Elixir Pharmaceuticals, Inc. N/A N/A N/A N/A N/A N/A

Lead Underwriter

N/A

Description

Elixir Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Oct 8, 2007 ZARS Pharma N/A N/A N/A N/A N/A N/A

Lead Underwriter

Cowen & Co and CIBC World Markets.

Description

ZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs using our proprietary drug delivery technologies, primarily in the area of pain management.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Jul 27, 2007 Quark Pharmaceuticals QURK $12-$14 N/A N/A N/A N/A

Lead Underwriter

JPMorgan Chase and Bank of America.

Description

Quark is an evolving pharmaceutical company using rational drug design to develop new therapeutics for unmet medical needs.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Jun 27, 2007 EndoCeutics ENCX N/A N/A $75M N/A N/A

Lead Underwriter

First Albany Capital, Oppenheimer & Co. and Stifel Nicolaus will underwrite the IPO.

Description

Canada's EndoCeutics Inc., a pharmaceutical firm developing hormone therapies for breast cancer and other endocrine-related disorders.

Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Mar 7, 2007 OncoGenex Technologies Inc. N/A N/A N/A $48M N/A N/A

Lead Underwriter

RBC Capital Markets will be the sole lead manager for the Offering, and the co-managers will be Needham & Company, LLC, Lazard Capital Markets LLC, Canaccord Adams Inc. and Susquehanna Financial Group, LLLP.

Description

OncoGenex is committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.


Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Dec 5, 2006 ImaRx Therapeutics N/A $10-$12 N/A N/A N/A N/A

Lead Underwriter

N/A

Description

ImaRx Pharmaceutical Corp., was founded in 1991 to develop contrast agents for radiology. It is our roots in the imaging field that gave us our name: ImaRx = Imaging and pharmaceuticals (Rx).


Date (Withdrawn)

Name

Ticker

Price Range

Issue Size

Offering Amt

Post Offering Shares

Est. Market Value

Oct 23, 2006 Asthmatx, Inc. N/A N/A N/A N/A N/A N/A

Lead Underwriter

Piper Jaffray & Co. and Bear, Stearns & Co. Inc. were slated to serve as joint book-running managers for the offering, with First Albany Capital Inc. and Jefferies & Company, Inc. serving as co-managers.

Description

Asthmatx Inc. is a medical device company focused on developing and commercializing a novel therapeutic treatment for asthma.


Date (Withdrawn) Company Symbol Price Shares Offering Amt Post Offering Shares Est. Market Value
Aug 4, 2006 Amicus Therapeutics, Inc. N/A N/A N/A N/A N/A N/A

Lead Underwriter

N/A

Description

Amicus Therapeuticsis a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases.


Date (Withdrawn) Company Symbol Price Shares Offering Amt Post Offering Shares Est. Market Value
Jul 27, 2006 Caprion Pharmaceuticals N/A N/A N/A N/A N/A N/A

Lead Underwriter

N/A

Description

Caprion Pharmaceuticals Inc. is a clinical-stage biotechnology company developing pharmaceutical products in the areas of infectious disease and oncology.


Date (Withdrawn) Company Symbol Price Shares Offering Amt Post Offering Shares Est. Market Value
Jul 10, 2006 QUATRx Pharmaceuticals N/A N/A N/A N/A N/A N/A

Lead Underwriter

N/A

Description

QuatRx is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas.


Date (Withdrawn) Company Symbol Price Shares Offering Amt Post Offering Shares Est. Market Value
Feb 17, 2006 Novogen Limited N/A N/A N/A N/A N/A N/A

Lead Underwriter

N/A

Description

Corus Pharma is a biopharmaceutical company committed to developing and commercializing products for severe respiratory and infectious diseases that can help provide improved health and superior quality of life.


Date (Withdrawn) Company Symbol Price Shares Offering Amt Post Offering Shares Est. Market Value
Jan 11, 2006 Glycotex, Inc. N/A N/A N/A N/A N/A N/A

Lead Underwriter

N/A

Description

Glycotex, Inc. is a clinical stage biopharmaceutical company focused on discovering and developing a novel class of drugs for human wound healing and tissue repair.



 

//-->